For media inquiries, please contact Lise Bram, ADAA Deputy Executive Director: lbram@adaa.org
Organizational News
-
ADAA Congratulates Scott Rauch, MD, Board Secretary, on his Election to the National Academy of Medicine, October 29, 2019
-
KidGuard Grant Awarded to ADAA - November 15, 2018
-
ADAA Statement on PTSD, Panic, and Sexual Assault - September 26, 2018
-
ADAA Statement on the Tragic Losses of Kate Spade and Anthony Bourdain - June 8, 2018
-
ADAA Welcomes Luana Marques, PhD as President-Elect - April 13, 2018
-
ADAA Has Been Nominated for the 2018 Change Maker Award! - March 9, 2018
-
A Message from the ADAA Board - January 10, 2018
-
ADAA Welcomes Beth Salcedo, MD as New Board President - January 3, 2018
-
Hope and Grace Fund Grant Awarded to ADAA - October 27, 2017
ADAA 2020 Conference News - Medscape.com
The findings were scheduled to be presented this month at the Anxiety and Depression Association of America (ADAA) Conference 2020, along with publication in the Journal of Affective Disorders. However, the ADAA conference was cancelled in the wake of the coronavirus pandemic.
- 04/07/2020 Worry, Anxiety Tied to Increased Inflammation, (ADAA Member) Megan Elizabeth Renna, PhD
- 04/06/2020 Rapid Response to PTSD Therapy May Predict Long-term Improvement
- 04/03/2020 IV Esketamine, Ketamine Equally Effective for Resistant Depression
- 03/31/2020 Mindfulness Interventions Linked to Cognitive Benefit, (ADAA member) Nur Hani Zainal, MS
ADAA 2019 Conference News
-
Disturbed Sleeps Derails Therapy for Complicated Grief, Medscape Medical News, April 9, 2019
-
Ketamine a Panacea for Resistant Depression? Not So Fast, Experts Say,Medscape Medical News, April 4, 2019
-
Self-Help App Helps Reduce Depression, Anxiety Symptoms, Healio, April 3, 2019
-
Songwriting May Hit the Right Therapeutic Note in PTSD, Medscape Medical News, April 3, 2019
-
Immunosuppressant May Extend Ketamine's Antidepressant Effects, Medscape Medical News, April 2, 2019
-
Patients with Anxiety, Mood Disorders Lack Self-compassion, Healio, April 1, 2019
-
Ketamine Improves Suicidal Ideation in Veterans with PTSD, MDD, Healio, April 1, 2019
-
Combination Therapy for PTSD Provides No Added Benefit, Medscape Medical News, April 1, 2019
-
Positive Pilot Phase 3 Data Position VistaGen’s PH94B Neuroactive Nasal Spray for Pivotal Phase 3 Development as a Novel, As-Needed Treatment for Social Anxiety Disorder, VistaGen Therapeutics Press Release (research poster presented at #ADAA2019), April 1, 2019
-
#ADAA2019 Conference - Press Release - January 14, 2019
Also visit our ADAA in the News, ADAA Members in the News and Executive Director's Corner pages for additional ADAA news updates.
KidGuard Grant Awarded to ADAA
Over the last several years, rates of childhood depression have continued to rise. Yet, information and awareness about childhood depression has not kept pace with this alarming trend. With increased exposure to social media, children are at greater risk of experiencing cyber-bullying and negative situations that can increase their anxiety, put them at risk for depression and in more severe cases, suicide. Funding from the KidGuard grant will help ADAA enhance our current educational content and mental health resources for children and teens. These resources include consumer webinars, child-friendly infographics, blog posts and educational videos covering topics such as childhood depression and anxiety, how to identify symptoms and where to find effective and suitable treatment options. Read the full press release.
#ADAA2019 Conference - Press Release
ADAA Statement on PTSD, Panic, and Sexual Assault
As clinicians, scientists, and professors who are experts in the fields of anxiety, depression,
and trauma, the recent media coverage of trauma and sexual assault have moved us to
comment, not on the particulars discussed, but on the potential impact on the patients to
whom we have committed our careers to help. Read the full statement.
ADAA Statement on the Tragic Losses of Kate Spade and Anthony Bourdain
This week we have lost Kate Spade and now Anthony Bourdain to suicide. The Board of the Anxiety and Depression Association of America (ADAA) offers our condolences to their families and to those touched by the lives of these two celebrated Americans.
Unfortunately, they are not alone. There will be 45,000 other deaths by suicide in this country within the year. One million worldwide. And that number, sadly, is growing. The CDC just released the results of a study this week showing that in a majority of US states, suicide has risen by almost 30% from 1999 to 2016. About half of those had a known mental health issue that was a likely contributor. Read more.
ADAA Welcomes Luana Marques, PhD as President-Elect
ADAA is pleased to announce that Luana Marques, PhD has been elected President-Elect of the ADAA Board of Directors and will assume the Board Presidency in January of 2020. Dr. Marques has been an active member of ADAA since 2008 and has served on the board since 2016. Dr. Marques is an ADAA Clinical Fellow, serves as the board liaison to the ADAA Annual Conference Committee, the Professional Education Committee, the PTSD Special Interest Group and the Multicultural Advances Special Interest Group. Read more.
ADAA Has Been Nominated for the 2018 Change Maker Award! - March 9, 2018
The winner will be decided as a result of online voting which is open through March 23. We would really appreciate your support for us by voting for us today and spreading the word! Please note: one vote per email address per day may be entered. Read the full press release.
#ADAA2018 Conference Press Release - February 15, 2018
Depressive disorders affect close to 19 million American adults. More than 50 percent of people diagnosed with depression are also co-diagnosed with an anxiety disorder. Coexisting anxiety and depression account for the most disabling mental health disorders in the United States. Read the full press release.
A Message from the ADAA Board - Year-End Reflections: Growth, Engagement and Impact - January 10, 2018
2017 has been a very busy year for ADAA! The San Francisco Annual Conference in April was a very successful highlight. With a record number of attendees (over 1,300) from across the United States and around the world attending more than 170 innovative sessions, listening to engaging keynotes and participating in special symposia, ADAA shone an important spotlight on behavioral medicine and its application to anxiety and depressive disorders. The 2018 Annual Conference will be held in DC this coming April and will focus on treatment-resistant anxiety and depression: challenges and opportunities. We look forward to another engaging 4 days of learning, sharing and connecting. ADAA is delighted to be offering conference attendees audio recordings of selected conference sessions (over 30 hours of programming, including up to 9 hours of CE). This is a great opportunity for attendees to enjoy enduring conference materials by offering the option to listen to sessions they might not have had time to attend live or to revisit their favorite sessions again, including Master Clinician sessions. Read the full statement.
ADAA Welcomes Beth Salcedo, MD as New Board President - January 3, 2018
Dr. Salcedo succeeds Karen L. Cassiday, PhD, who served as ADAA BOD President from 2015-2017. Dr. Cassiday will now serve as Immediate Past Board Chair.
Dr. Salcedo has been an active member of ADAA since 2004, serving on the Executive Council as President Elect since 2016. Dr. Salcedo is an ADAA Clinical Fellow and co-chairs ADAA's Women's Special Interest Group. She is a psychiatrist with expertise in diagnostic assessment and psychopharmacologic management of anxiety and mood disorders in adults. Dr. Salcedo has been the medical director of The Ross Center since 2002, and has been with the center since 1997. She has also served as Assistant Clinical Professor, Psychiatry and Behavioral Sciences at the George Washington University College of Medicine and Health Sciences. Dr. Salcedo has been named in Washingtonian magazine's "Top Doctors" consistently since 2010. Read more.
Hope and Grace Fund Grant Awarded to ADAA - October 29, 2017
Through this new project, ADAA will form a Women’s Special Interest Group to design women-focused programming for mental health professionals. It will also develop programming for its 2018 annual conference that focuses on evidence-based gender research and treatment options for women. Finally, ADAA will create women-focused webinars and outreach to educate the public about mental health treatment options for women and to decrease the stigma of mental illness. This project will educate at least 100 clinical researchers and clinicians on female-focused mental health research and treatment trends, while also disseminating educational information about mental health to more than a million women of all ages. Through this initiative, ADAA will reduce the stigma of mental illness, connect women to specialized treatment, and foster dialogue between women’s mental health researchers, clinicians, patients, and the public at large.